Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijrobp.2018.01.067PMID 29619965PMCID PMC5999036
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcomes of cervical cancer among HIV-infected and HIV-uninfected women treated at the Brazilian National Institute of Cancer

  2017influential reference
• Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries.

  2017cited by this paper
• Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline

  2016cited by this paper
• HIV Infection and Survival Among Women With Cervical Cancer.

  2016cited by this paper
• Acute toxicity in cervical cancer HIV-positive vs. HIV-negative patients treated by radical chemo-radiation in Zambia

  2016cited by this paper
• HIV positivity and anal cancer outcomes: A single-center experience.

  2016cited by this paper
• Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey.

  2016cited by this paper
• Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project - Botswana, 2013.

  2015cited by this paper
• Optimal management of cervical cancer in HIV-positive patients: a systematic review

  2015cited by this paper
• Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs

  2015cited by this paper
• Cancer Incidence following Expansion of HIV Treatment in Botswana

  2015cited by this paper
• Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States.

  2015influential reference
• HIV Status and Acute Hematologic Toxicity Among Patients With Cervix Cancer Undergoing Radical Chemoradiation

  2015cited by this paper
• Cancer Treatment in Patients With HIV Infection and Non-AIDS-Defining Cancers: A Survey of US Oncologists.

  2015cited by this paper
• Cervical brachytherapy exchange: steps toward oncology capacity building in Botswana.

  2014cited by this paper
• Hemoglobin Level in Cervical Cancer: A Surrogate for an Infiltrative Phenotype

  2013cited by this paper
• Predictors of risky sexual behaviour among young people in the era of HIV/AIDS: evidence from the 2008 Botswana AIDS Impact Survey III.

  2013cited by this paper
• Addressing the growing cancer burden in the wake of the AIDS epidemic in Botswana: The BOTSOGO collaborative partnership.

  2013cited by this paper
• Trends in the utilization of brachytherapy in cervical cancer in the United States.

  2013cited by this paper
• Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study.

  2012cited by this paper
• Cervical Cancer Prevention in HIV-Infected Women Using the “See and Treat” Approach in Botswana

  2012cited by this paper
• Completion of and early response to chemoradiation among human immunodeficiency virus (HIV)‐positive and HIV‐negative patients with locally advanced cervical carcinoma in South Africa

  2012cited by this paper
• Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.

  2012cited by this paper
• Cervical Cancer Awareness and Screening in Botswana

  2012cited by this paper
• High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort

  2011cited by this paper
• Landmark Analysis at the 25-Year Landmark Point

  2011cited by this paper
• Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.

  2010cited by this paper
• Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy.

  2009cited by this paper
• Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.

  2009cited by this paper
• Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women.

  2009cited by this paper
• Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.

  2009cited by this paper
• Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.

  2006cited by this paper
• Low CD4+ T-cell counts in HIV patients receiving effective antiretroviral therapy are associated with CD4+ T-cell activation and senescence but not with lower effector memory T-cell function.

  2006cited by this paper
• A phase I study of concurrent cisplatin chemotherapy in patients with carcinoma of the cervix receiving pelvic radiotherapy

  2006cited by this paper
• HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome.

  2005cited by this paper
• Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

  2004cited by this paper
• Prognostic factors in definitive radiotherapy of uterine cervical cancer.

  2003cited by this paper
• Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis.

  2003cited by this paper
• T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

  2003cited by this paper
• FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.

  2000cited by this paper
• Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.

  1996cited by this paper
• Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

  1995cited by this paper
• Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

  1995cited by this paper
• The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma

  1948cited by this paper

• Efficacy of induction chemotherapy during the COVID-19 pandemic for treatment of locally advanced cervical cancer in Botswana.

  2025cites this paper
• Molecular, immunological and oncogenic mechanisms of cervical cancer mediated by HPV/HIV co-infection, clinical implication and management

  2025cites this paper
• Cervical Cancer Outcomes and Toxicity in HIV-Positive Women Treated With Radiation or Chemoradiation: A Systematic Review

  2025influential citation
• Addressing the cancer burden in LMICs: the potential of modulated electro-hyperthermia

  2025cites this paper
• Comparison of high-grade human papillomavirus-induced cervical lesions between human immunodeficiency virus-positive and human immunodeficiency virus-negative women

  2025cites this paper
• Assessing the impact of multidisciplinary team gynecological oncology care in Botswana: A potential model for low‐ and middle‐income countries

  2025cites this paper
• Cervical cancer treatment outcomes and survival in Botswana by human immunodeficiency virus status: Ipabalele study results

  2025cites this paper
• A systematic review and meta-analysis of side effects influenced by non-surgical treatments in African cancer patients

  2025influential citation
• Patients with Cervical Cancer with and without HIV Infection Have Unique T-cell Activation Profiles despite Similar Survival Outcomes after Chemoradiation

  2025cites this paper
• Longitudinal study on quality of life following cervical cancer treatment in Botswana

  2025cites this paper
• Patterns of Care and Outcomes Among Women With Locally Advanced Cervical Cancer Treated With Curative Intent at a Tertiary Center in South Africa

  2025cites this paper
• Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana

  2024influential citation
• Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review

  2024cites this paper
• Current management of cervical cancer in women living with HIV.

  2024cites this paper
• Cancer in People with HIV.

  2024cites this paper
• Delays in cervical cancer treatment initiation for patients living with or without HIV in Botswana: An observational cohort analysis (2015-2019).

  2024cites this paper
• Impact of HIV infection on access to cancer care and survival among women with invasive cervical cancer in Côte d'Ivoire: A prospective cohort study

  2023cites this paper
• Cervical cancer in Mozambique: Clinical characteristics, treatment and survival of incident cases admitted to the Oncology Service of Maputo Central Hospital in 2016‐2018

  2023cites this paper
• Benchmarking of the Cervical Cancer Care Cascade and Survival Outcomes After Radiation Treatment in a Low- and Middle-Income Country Setting

  2023cites this paper
• Implementation of Brachytherapy for Patients With Cervical Cancer in Ethiopia: A 3-Year Practice Report

  2023cites this paper
• Access to Radiation Therapy and Related Clinical Outcomes in Patients With Cervical and Breast Cancer Across Sub-Saharan Africa: A Systematic Review

  2023cites this paper
• Cervical cancer survival times in Africa

  2022cites this paper
• Tumor draining lymph nodes, immune response, and radiotherapy: Towards a revisal of therapeutic principles.

  2022cites this paper
• Gynecological radiotherapy in people living with human immunodeficiency virus: a semi-systematic literature review

  2022cites this paper
• Outcomes of Cervical Cancer in HIV-Positive Women Treated With Radiotherapy at a Tertiary Care Center in India

  2022cites this paper
• Patient perspectives on delays in cervical cancer screening and follow-up care in Botswana: a mixed methods study

  2022cites this paper
• Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting

  2022cites this paper
• Clinical Characteristics and Prognosis of Cervical Cancer Patients with Human Immunodeficiency Virus Infection: A Retrospective Study

  2022cites this paper
• Cancer treatment and survival among cervical cancer patients living with or without HIV in South Africa

  2022cites this paper
• Stage and outcomes of invasive cervical cancer patients in Botswana: A prospective cohort study from 2013 to 2020

  2022cites this paper
• The molecular basis of immuno-radiotherapy

  2022cites this paper
• Cervical human papillomavirus genotypes in a high HIV setting: A scoping review of a decade of human papillomavirus epidemiological research in Botswana

  2022cites this paper
• Impact of Antiretroviral Therapy on Cancer Treatment Outcomes among People Living with HIV in Low- and Middle-Income Countries: a Systematic Review

  2021cites this paper
• Anlotinib in Chinese Patients With Recurrent Advanced Cervical Cancer: A Prospective Single-Arm, Open-Label Phase II Trial

  2021influential citation
• Cervical cancer prevention and control in women living with human immunodeficiency virus

  2021cites this paper
• Cervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes.

  2021cites this paper
• Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana

  2021cites this paper
• Vulvar cancer in Botswana in women with and without HIV infection: patterns of treatment and survival outcomes

  2021cites this paper
• Five-year overall survival following chemoradiation therapy for locally advanced cervical carcinoma in women living with and without HIV infection in Botswana

  2021cites this paper
• Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus

  2021cites this paper
• Epidemiology of cervical adenocarcinoma and squamous cell carcinoma among women living with HIV compared to the general population in the United States.

  2021cites this paper
• Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: A systematic review

  2021cites this paper
• Cervical Cancer Treatment in HIV-Positive Patients: A Survey of Treatment Practices in India

  2021cites this paper
• Promoter Hypermethylation Analysis of Host Genes in Cervical Cancer Patients With and Without Human Immunodeficiency Virus in Botswana

  2021cites this paper
• The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical Cancer.

  2020cites this paper
• Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana

  2020cites this paper
• A prognostic study of patients with cervical cancer and HIV/AIDS in Bangkok, Thailand

  2020cites this paper
• Management of Head and Neck Cancers With or Without Comorbid HIV Infection in Botswana

  2020cites this paper
• Apatinib combined with chemotherapy or concurrent chemo-brachytherapy in patients with recurrent or advanced cervical cancer

  2020cites this paper
• Meeting the Global Need for Radiation Therapy in Cervical Cancer-An Overview.

  2020cites this paper
• Tumor microbial diversity and compositional differences among women in Botswana with high-grade cervical dysplasia and cervical cancer

  2020cites this paper
• Association between CD4 count and chemoradiation therapy outcomes among cervical cancer patients with HIV.

  2020cites this paper
• Differences in outcomes of chemoradiation in women with invasive cervical cancer by HIV status: a systematic review.

  2020cites this paper
• Comparison of survival outcomes by different treatments for HIV-infected cervical cancer: a real-world study in a single center in China

  2020cites this paper
• The impact of HIV status on staging, treatment and outcomes in locally advanced cervical carcinoma

  2019cites this paper
• Epidemiological trends and therapeutic challenges of malignancies in adult HIV-1-infected patients receiving combination antiretroviral therapy in a tertiary hospital from Romania: An observational retrospective study.

  2019cites this paper
• Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in Botswana

  2019cites this paper
• The impact of venous thromboembolism on the outcomes of patients with cervical carcinoma, a retrospective analysis at a single institution

  2019cites this paper
• HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana

  2019cites this paper
• Tearing down the false walls to HIV cancer care

  2019cites this paper
• Global Collaborations for Cervical Cancer: Can the East-West Alliance Facilitate Treatment for all?

  2019cites this paper
• Patterns of Care of Cancers and Radiotherapy in Ethiopia

  2019influential citation
• The association between HIV infection and cervical cancer presentation and survival in Uganda

  2019cites this paper
• Factors Related to Advanced Stage of Cancer Presentation in Botswana

  2018cites this paper
• Five-year overall survival following chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in a South African cohort.

  2018cites this paper